MRI-identified multidimensional nodal features: predict survival and concurrent chemotherapy benefit for stage II nasopharyngeal carcinoma: LN feature-based nomogram for stage II NPC . Radiology and Oncology, v. 56, n. 4, p. 479–487, 5 Dec.2022.